Safety evaluation of fixed‐dose nivolumab in patients with gastric cancer

Safety evaluation of fixed‐dose nivolumab in patients with gastric cancer

Abstract Background and Aims This study aimed to examine the safety of fixed‐dose nivolumab. Methods We retrospectively reviewed the medical records of 113 Japanese patients with gastric cancer who were previously treated with cytotoxic chemotherapy and initiated nivolumab. The endpoints were the in...

Full description

Bibliographic Details
Main Authors: Yusuke Iikura, Takeshi Aoyama, Makoto Hiraide, Takeru Wakatsuki, Izuma Nakayama, Mariko Ogura, Akira Ooki, Daisuke Takahari, Keisho Chin, Kensei Yamaguchi, Toshihiro Hama
Format: Article
Language:English
Published: Wiley 2022-07-01
Series:Health Science Reports
Subjects:
fixed dose
gastric cancer
immune‐related adverse event
nivolumab
programmed death receptor‐1
Online Access:https://doi.org/10.1002/hsr2.673

Internet

https://doi.org/10.1002/hsr2.673

Similar Items